Navigation Links
InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
Date:3/6/2009

Better Antibodies and today, we demonstrated that once again."

InNexus also announced that Jeff Morhet, Chairman and CEO, was recently highlighted and quoted in an article titled "JAMA study casts cloud over biologic safety" in the January 2009 issue of Nature Biotechnology. A copy of the article can be downloaded at: http://www.nature.com/nbt/journal/v27/n1/pdf/nbt0109-11.pdf. Nature Biotechnology is a widely read academic journal published by Nature Publishing Group, a division of Macmillan Publishers Ltd., covering the science and business of biotechnology.

About InNexus

InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its DXL(TM) technology, which improves the potency of existing antibody products while opening new markets and disease applications. DXL(TM) antibodies utilize unique, novel and patented methods and technologies of InNexus.

InNexus is headquartered in British Columbia with principal management based in Scottsdale, Arizona on the campus of Mayo Clinic and has its own in-house developmental facilities. These development resources provide validation of protein and peptide discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics and diagnostics. To learn more about InNexus, please visit www.ixsbio.com.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release. This news release may contain assumptions, estimates, and other forward-looking statements that involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company's control, that may cause actual results or performance to differ materially from those currently antici
'/>"/>

SOURCE InNexus Biotechnology Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Provides A Positive Review of InNexus Biotechnology Development Plan for Lead Product
2. InNexus Completes Previously Announced Private Placement
3. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
4. InNexus Biotechnology Receives Patent Grants in Europe
5. InNexus Biotechnology CEO to Present at the 7th Annual BIO Investor Forum
6. InNexus Biotechnology CEO to Present at BioContactQuebec 2008
7. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
8. InNexus Biotechnology Strengthens Patent Team With New Leadership
9. InNexus Biotechnology CEO to Present at The Wall Street Analyst Forum in NYC
10. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
11. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2015)...  The Heinz Family Foundation today announced the ... which will present unrestricted cash awards totaling $1.25 ... and determination in finding solutions to critical issues ... recipients include a prolific cartoonist whose quirky characters ... relationships; two former Marines who are re-engaging veterans ...
(Date:4/22/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE and EURONEXT Paris:BIOA) today announced that it ... on Thursday, May 7, 2015 after the close of ... conference call for 4.30 pm ET (1.30 pm PT) ... of the conference call will be webcast over the ... the news media and the general public. To access ...
(Date:4/22/2015)... Today, DuPont announced it has agreed ... discovery company. This acquisition will build on DuPont’s ... seed and crop protection to discover and commercialize ... “In 2014, the businesses in DuPont’s Agriculture, Nutrition ... than $1 billion in biological solutions across four ...
(Date:4/22/2015)... 2015 2015 HIMSS Annual Conference & ... of the 9th annual Venture+ Forum pitch competition for ... selected to deliver live pitch presentations to a panel ... HIMSS15 held last week in Chicago ... professionals and 1,200 exhibiting companies from around the world, ...
Breaking Biology Technology:From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 2From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 3From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 4From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 5From a Scientist Who Develops Human Microlivers to a New Yorker Cartoonist Who Masterfully Depicts the Humor and Heartbreak of Everyday Life: The 20th Heinz Awards Honors Six Changemakers 6BioAmber Announces Webcast of Fiscal First Quarter 2015 Financial Results 2DuPont Acquires Taxon Biosciences, Inc. 2DuPont Acquires Taxon Biosciences, Inc. 3DuPont Acquires Taxon Biosciences, Inc. 4TowerView Health Named Venture+ Forum Pitch Competition Winner At HIMSS15 2TowerView Health Named Venture+ Forum Pitch Competition Winner At HIMSS15 3
... Talent Management Vendor,s Model ... Market, OTTAWA, Feb. 26 /PRNewswire/ - Halogen Software ... management software,today announced that FactPoint Group has profiled Halogen ... market. The Silicon Valley based research and,consulting firm selected ...
... Inc., a company focused,on developing novel therapies targeting ... Bussineau, Ph.D., to the,position of vice president of ... vice president, business development and nonvascular,operations., "Dr. ... experience to,BioVascular that will allow us to advance ...
... Ambrx Inc. today announced the,appointment of Douglas ... Clinical Research and Development., Axelrod joins Ambrx ... Procter & Gamble Pharmaceuticals. Most recently, he served ... and Product,Development where he accelerated the discovery process, ...
Cached Biology Technology:FactPoint Group Recognizes Halogen for "On-Choice" Deployment Model 2BioVascular, Inc. Expands Executive Team 2Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development 2
(Date:4/8/2015)...  Infinisource, a leading provider of SaaS-based Human Capital ... leading supplier of biometric identification and security solutions, ... advanced biometrically-enabled time clock, the companies announced today. ... setting a bold, new standard for the collection ... and mid-size employer. When connected to the iSolved ...
(Date:4/2/2015)... April 2, 2015 In ... by far outperforms the strongest competitors, showing outstanding ... accuracy, the system is capable of a throughput ... proves up to be ten times faster than ... runner-up performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... revenues for Q1 2015 attributed to somewhat higher than ... company in the year-end report 2014 that revenues for ... MSEK that the company reported for Q4 2014. The ... continue to be negative. The complete interim report will ...
Breaking Biology News(10 mins):iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2
... 17, 2009 Representatives of the nation,s leading public ... and other Members of Congress, today announced the launch ... research and related activities that have been made possible ... (ARRA), also known as the stimulus. The ...
... be as intelligent as much bigger animals, despite only ... scientists at Queen Mary, University of London. "Animals ... to Lars Chittka, Professor of Sensory and Behavioural Ecology ... of Cambridge colleague, Jeremy Niven. This begs the important ...
... Two University of New Hampshire assistant professors ... Early Career Development (CAREER) grants. Vaughn Cooper of ... received $1 million to better understand beneficial mutations ... data collection. Christopher White of the mechanical engineering ...
Cached Biology News:Members of Congress, university leaders, scientists launch ScienceWorksForUS 2Members of Congress, university leaders, scientists launch ScienceWorksForUS 3Members of Congress, university leaders, scientists launch ScienceWorksForUS 4Bigger not necessarily better, when it comes to brains 22 UNH faculty receive $1.4M in CAREER grants from NSF 2
... Rabbit polyclonal to MKK6 (phospho S207) ... applications). Antigen: ... around the phosphorylation site of Serine ... Entrez Gene ID: 5608 ...
Rabbit polyclonal to Reptin/TIP49B/RUVB2 ( Abpromise for all tested applications). Antigen: Synthetic peptide (Human) Entrez Gene ID: 10856 Swiss Protein ID: Q6FIB9...
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications)....
Goat polyclonal to ORC2L ( Abpromise for all tested applications). entrezGeneID: 4999 SwissProtID: Q13416...
Biology Products: